INTRODUCTION: Only 2.4% of the 16.5-kb mitochondrial DNA (mtDNA) genome shows homoplasmic variation at >1% frequency in humans. Migration patterns have contributed to geographic differences in the frequency of common genetic variants, but population genetic evidence indicates that selection shapes the evolving mtDNA phylogeny. The mechanism and timing of this process are not clear.
Unlike the nuclear genome, mtDNA is maternally transmitted and there are many copies in each cell. Initially, a new genetic variant affects only a proportion of the mtDNA (heteroplasmy). During female germ cell development, a reduction in the amount of mtDNA per cell causes a "genetic bottleneck," which leads to rapid segregation of mtDNA molecules and different levels of heteroplasmy between siblings. Although heteroplasmy is primarily governed by random genetic drift, there is evidence of selection occurring during this process in animals. Yet it has been difficult to demonstrate this convincingly in humans.
RATIONALE: To determine whether there is selection for or against heteroplasmic mtDNA variants during transmission, we studied 12,975 whole-genome sequences, including 1526 motheroffspring pairs of which 45.1% had heteroplasmy affecting >1% of mtDNA molecules. Harnessing both the mtDNA and nuclear genome sequences, we then determined whether the nuclear genetic background influenced mtDNA heteroplasmy, validating our findings in another 40,325 individuals.
RESULTS: Previously unknown mtDNA variants were less likely to be inherited than known variants, in which the level of heteroplasmy tended to increase on transmission. Variants in the ribosomal RNA genes were less likely to be transmitted, whereas variants in the noncoding displacement (D)-loop were more likely to be transmitted. MtDNA variants predicted to affect the protein sequence tended to have lower heteroplasmy levels than synonymous variants. In 12,975 individuals, we identified a correlation between the location of heteroplasmic sites and known D-loop polymorphisms, including the absence of variants in critical sites required for mtDNA transcription and replication. We defined 206 unrelated individuals for which the nuclear and mitochondrial genomes were from different human populations. In these individuals, new population-specific heteroplasmies were more likely to match the nuclear genetic ancestry than the mitochondrial genome on which the mutations occurred. These findings were independently replicated in 654 additional unrelated individuals.
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P
rimarily inherited from the maternal line, the 16.5-kb human mitochondrial DNA (mtDNA) genome acquired mutations sequentially after modern humans emerged out of Africa (1-3). Pedigree and phylogenetic analyses have estimated a de novo mtDNA nucleotide substitution rate of~10
substitutions per base pair per year (4). However, from 30,506 mitochondrial genome sequences from across the globe (5), only 2.4% of nucleotides show genetic variation with >1% frequency within a population (Fig. 1) . Although the idea has been the subject of debate (6, 7), selection might contribute to the nonrandom distribution of common variants across the mitochondrial genome in the human population.
Heteroplasmic mtDNA variants are common and maternally inherited
We analyzed high-depth mtDNA sequences from 1526 mother-offspring pairs (mean depth in the mothers = 1880×, range = 249× to 7454×; mean depth in the offspring = 1901×, range = 259× to 7475×; mothers versus offspring, P = 0.49, twosample t test) ( fig. S1 ). We called homoplasmic and heteroplasmic mtDNA variants from wholeblood DNA sequence data (8, 9) and filtered out heteroplasmic calls that are likely attributable to errors (9) (10) (11) S3) , with mothers having more heteroplasmic variants than offspring (mean number in the mothers = 0.68, range = 0 to 6; mean number in the offspring = 0.58, range = 0 to 4; P = 0.002, effect size = 0.68, Wilcoxon rank sum test) ( Fig. 2A) .
We defined three categories of heteroplasmic variants: (i) transmitted or inherited, if the variant was present in the mother and the offspring and was heteroplasmic in at least one of the two; (ii) lost, if the heteroplasmic variant was present in the mother but not detectable in the offspring; and (iii) de novo, if the heteroplasmic variant was present in the offspring but not detectable in the mother (table S1) (9) . Because our sequencing and bioinformatics pipeline may have missed very low level heteroplasmies (<1% VAF), lost and de novo variants could potentially be present at very low levels in, respectively, the offspring's and mother's germ line. The heteroplasmic fraction (HF) of transmitted heteroplasmic variants (mean HF = 19.5%, SD = 13.9%) was significantly higher than the HF of lost variants (mean HF = 5.6%, SD = 6.3%) in the mothers (P < 2.2 × 10 −16 , effect size = 4.24, Wilcoxon rank sum test), and the HF of inherited heteroplasmic variants (mean HF = 19.8%, SD = 14.1%) was significantly higher than that of de novo variants (mean HF = 6.2%, SD = 7.4%) in the offspring (P < 2.2 × 10 (Fig. 2C) . In total, 477 de novo heteroplasmic variants not seen in the mother were observed at >1% HF in the offspring, consistent with previous estimates (13) . To ensure that these data were not due to technical errors, we determined whether any heteroplasmic variants in the offspring were also present in their fathers. Among 313 fatheroffspring pairs, the offspring harbored 196 heteroplasmic variants with HF >1%, and only 1 of these was also observed in the corresponding father. This was a common population variant [population minor allele frequency (MAF) = 25.8% (5)] in the displacement (D)-loop region (m.152T>C), which was homoplasmic in the father and had an HF of 12.4% in his child. The alternate allele was not detected in the mother, which suggests that this region is a recurrent site of mutation or that the variant is conceivably due to the paternal transmission of mtDNA.
The difference between HF in mothers and their offspring can be measured in percentage points (Fig. 2D) (14) . This metric is limited by the difference between the HF of the offspring and that of the mother, as well as by the boundaries 0 and 100%. The magnitude of the percentage change differs from the magnitude of the fold change in VAF. For example, a change from 50 to 55% would be given the same value as a change from 1 to 6%, even though the latter implies a sixfold increase in the proportion of mtDNA carrying the alternate allele. We therefore studied the log 2 ratio of HF between offspring and mothers after imputation of HF values below 1% to our detection threshold of 1% [subsequently termed the heteroplasmy shift (HS)] (Fig. 2 , E and F) (9) , which shrunk HSs toward zero only when the true HF in either the mother or the offspring was below 1%.
Overall, there was no significant difference between the number of heteroplasmic variants with a positive (n = 731) and a negative (n = 798) HS (P = 0.091, binomial test). The HS distribution around zero was moderately symmetric and yielded a marginal P value for asymmetry (P = 0.05, one sample t test) (Fig. 2, D and E), consistent with random segregation of mitochondria during meiosis (14, 15) . All of the HSs were <6 in magnitude, corresponding to a <64-fold increase or decrease in HF across one generation, with 2 of 12 three exceptions. De novo variants at m.57 T>C (HF = 99.3%), m.8993T>G (HF = 82.1%), and m.14459G>A (HF = 93.6%) were detected in three unrelated offspring and were not present in the corresponding mothers (figs. S4 to S6). m.14459G>A is a nonsynonymous (NS) variant in ND6 that, on the basis of evidence from previously published pedigrees (16, 17) , causes Leber hereditary optic neuropathy and Leigh syndrome (dystonia). m.8993T>G is a NS variant in ATP6 (L156R) that has been observed on many independent occasions in Leigh syndrome or neurogenic ataxia with retinitis pigmentosa (17) (18) (19) . Although these extreme HSs could reflect differences in the mechanism of transmission for pathogenic mtDNA mutations (20) , ascertainment is a more likely explanation because participants with childhood-onset neurodegenerative diseases were recruited as part of this study (21) . Ascertainment bias is not likely to explain the de novo occurrence of m.57 T>C, but these findings indicate that extreme HSs at moderate HFs are not typical among humans.
As expected, the noncoding D-loop had the highest substitution frequency (7.64 × 10 −5 per base per genome per transmission) of all the regions in the mitochondrial genome ( Fig. 3A and table S2) (13) . In total, we observed 16 of 57 previously defined (5) pathogenic mutations in the 1526 mother-offspring pairs (Fig. 3B ). After excluding m.14459G>A and m.8993T>G, where the extreme HS likely reflects ascertainment bias, the mean HS for the remaining 14 pathogenic mutations was not significantly different from zero (P = 0.22, one sample t test) nor from the mean HS for the remaining 1076 nonpathogenic variants (P = 0.11, two sample t test). Thus, overall we did not see a strong signature of selection for or against pathogenic alleles, although our statistical analysis does not preclude that a subset of the observed pathogenic alleles may be under selection. Notably, only three mothers carried the most common heteroplasmic pathogenic mutation, m.3243A>G (22) , each with a low HF (5.2, 3.6, and 1.7%) that decreased to levels below our detection threshold in two of the three corresponding offspring (3.9, <1, and <1%). Six of the 16 pathogenic mutations were not detectable in the mothers, yielding a de novo mutation rate for known pathogenic mutations of 393 per 100,000 live births (95% CI = 144 to 854), which is~3.7-fold higher than the previously reported rate (23).
To gain insight into possible mutational mechanisms, we determined the trinucleotide mutational signature. As shown previously, C>T and T>C substitutions were the most common type of substitution in homoplasmic variants (5) and cancer somatic mtDNA mutations (24) . For heteroplasmic variants, C>T and T>C substitutions were also predominant, which suggests that germline transmission shapes the mutational signatures seen in homoplasmic variants at the population level. However, we also observed a small but significant excess of C>A, C>G, T>A, and T>G substitutions (P < 2.2 × 10 S7 ). Additionally, de novo mutations were more likely to involve a CpG-containing trinucleotide (P = 3.01 × 10 −6 , odd ratio = 0.50, 95% CI = 0.38 to 0.66, Fisher's exact test) (Fig. 3C ). Although controversial (25) , this could be because methylation of NpCpG sites on the mtDNA genome predisposes to de novo mtDNA mutations, as seen in the nuclear genome.
Known mtDNA variants are more likely to be transmitted than previously unknown variants
We then compared known heteroplasmic variants (i.e., those seen before in the general population) and those not previously observed. Variants were considered previously unknown if they were absent from the 1000 Genomes datasets and the Single Nucleotide Polymorphism Database (dbSNP) and were seen in at most one individual among 30,506 NCBI mtDNA sequences (5). Previously unidentified heteroplasmic variants were 4.7-fold less commonly transmitted from mother to offspring than known variants (P = 3.55 × 10
, odd ratio = 2.60, 95% CI = 1.97 to 3.45, Fisher's exact test), and the HS for transmitted known variants was more likely to be positive (P = 0.0002, probability = 0.40, 95% CI = 0.35 to 0.45, binomial test) (Fig. 3, D and E) . Also, the transmitted heteroplasmic variants were more likely to affect known haplogroup-defining sites (26) than the lost and de novo heteroplasmic variants (P = 7.86 × 10
, odds ratio = 0.40, 95% CI = 0.30 to 0.53, and P = 0.0016, odds ratio = 0.62, 95% CI = 0.46 to 0.84, respectively, Fisher's exact test) (Fig.  3F ). This suggests that factors may modulate the transmission of mtDNA heteroplasmy within the female germ line over a single generation and influence the likelihood that they become established within human mtDNA populations. Because heteroplasmic variants are acquired throughout life, they must be removed at transmission to offspring at a higher rate than they appear de novo; otherwise, each generation would be accompanied by an expected increase in potentially deleterious heteroplasmic variants (27) . Correspondingly, the number of previously unknown variants present in the mother but not transmitted (lost variants) exceeded the number of de novo unknown variants detected in the offspring (P = 7.93 × 10 −7 , probability = 0.62, 95% CI = 0.57 to 0.67, binomial test) (Fig. 3D) , in part reflecting the accumulation of heteroplasmic variants with increasing maternal age ( fig. S3 ).
Selection for and against heteroplasmy in different genomic regions
We analyzed different functional regions of the genome and found evidence indicating regionspecific selection for or against heteroplasmic variants. The distributions of HF in the 1526 mother-offspring pairs were significantly different between the D-loop, ribosomal RNA (rRNA), tRNA, and coding regions ( Fig. 4A and table S3 ). Within the coding region, the NS and synonymous (SS) variants also had different distributions (P = 2.74 × 10
, Kolmogorov-Smirnoff test). The NS/SS ratio was greater for the heteroplasmic variants than for the homoplasmic variants (P = 3.98 × 10 −24
, odds ratio = 1.91, 95% CI = 1.68 to 2.18, Fisher's exact test), and the de novo and lost heteroplasmic variants had a higher NS/SS than the transmitted variants (transmitted versus de novo: P = 0.0056, odds ratio = 1.69, 95% CI = 1.15 to 2.48; transmitted versus lost: P = 0.01, odds ratio = 1.57, 95% CI = 1.10 to 2.24, Fisher's exact test) (Fig. 4B) . The heteroplasmic variants were more often in conserved sites than the homoplasmic variants (P = 3.71 × 10 −77
, odds ratio = 3.21, 95% CI = 2.86 to 3.60, Fisher's exact test), and the transmitted heteroplasmic variants were less conserved than the de novo (P = 0.0018, odds ratio = 1.62, 95% CI = 1.19 to 2.22, Fisher's exact test) and lost (P = 9.60 × 10 −9
, odds ratio = 2.25, 95% CI = 1.69 to 3.03, Fisher's exact test) heteroplasmic variants (Fig. 4C) . Also, heteroplasmic variants with a positive HS were less conserved than those with a negative HS (P = 0.03, odds ratio = 1.28, 95% CI = 1.01 to 1.61, Fisher's exact test). Variants in the rRNA genes were more likely to show a decrease in the heteroplasmy level on transmission than an increase (P = 1.00 × 10 −4 , probability = 0.65, 95% CI = 0.57 to 0.72, binomial test) (Fig. 4D) , and the mean HS was significantly less than zero (P = 8.21 × 10
, d = 0.30, one sample t test) (Fig. 4E) . To understand the determinants of transmission of heteroplasmic variants with a reduced risk of confounding, we used multivariable logistic regression to model the probability of transmission across all 1526 mother-offspring pairs (9) . We modeled the transmission probability of a variant as a function of its HF in the mother, the identity of the mitochondrial genome region containing it, and its status as known or previously unknown (Figs. 3D and 4, F to H) (9). The probability that a heteroplasmic variant in the mother was transmitted to her offspring was associated with its HF in the mother (P < 2.2 × 10 −16
, coefficient estimate = 1.17, SD = 0.08, logistic regression) (Fig. 4F) . Variants in the D-loop were more likely to be transmitted (P = 0.04, coefficient estimate = 0.39, SD = 0.19, logistic regression) than average, and those in the rRNA were less likely to be transmitted (P = 0.0026, coefficient estimate = −0.94, SD = 0.31, logistic regression) than average (Fig. 4G) . The previously unrecognized variants were less likely to be transmitted than the known variants (P = 0.028, coefficient estimate = 0.43, SD = 0.19, logistic regression) (Fig. 3D) , even after accounting for all other covariates, including HF in the mothers.
Heteroplasmic variants in the noncoding D-loop
To cast light on the possible effects of selection on the noncoding D-loop, we derived a highresolution map of heteroplasmic variants in 12,975 individuals, which included the 1526 mother-offspring pairs (mean mtDNA genome depth = 1832×, SD = 945×; mean depth of Dloop = 1569×, SD = 819×) (Fig. 5, A to C, and  fig. S8 ) (9) . We found an association between the homoplasmic allele frequency among 30,506 NCBI mtDNA sequences and the proportion of (Fig. 5, A to  C) , similar to that previously observed (5) . Of the 17 regions in the D-loop (Fig. 5C , bottom, purple and orange bars), 2 had a significantly greater number of heteroplasmic variants than expected by chance. These regions correspond to the proposed replication fork barrier associated with the D-loop termination sequence (MT-TAS2) (28) and MT-CSB1 (MT-TAS2: P = 4.5 × 10 −11
, odds ratio = not identified on mtDNA phylogenies across a subset of 10,210 unrelated individuals from the original dataset (9) . Five of these heteroplasmic variants were shared by more than one individual and were present exclusively in people within a particular haplogroup (Fig. 5, D and E (Fig. 5F ) descended from the same maternal ancestor as the three homoplasmic individuals seen previously (5) and belonged to a closely related maternal lineage that had not yet reached fixation. These recurrent heteroplasmies contributed to the distinct trinucleotide mutational signature of the D-loop (P = 2.3 × 10 −137 , Stouffer's method for combining Fisher P values), which involves prominent noncanonical substitutions and is consistent with the conclusion that the homoplasmic trinucleotide mutational signature of mtDNA is shaped by germline transmission of heteroplasmic variants (Fig. 5D and fig. S9 ).
We observed an absence of low-level heteroplasmic variants in critical sites required for the initiation of mtDNA transcription and replication. These zones include several conserved sequence boxes and the light-strand promoter (MT-LSP: P = 7.7 × 10 −18
, odds ratio = 10.12, 95% CI =5.43 to 20.31, Fisher's exact test), which are required for mtDNA transcription and mtDNA replication (29) . Certain regions with no known function (30) (e.g., 16 ,400 to 16,500 bp; Fig. 5C ) also had a complete lack of low-level heteroplasmic variants, which suggests that an intact sequence at these regions is essential for mitochondrial function and perhaps genome propagation. The coordinates of the conserved and nonconserved regions provide a guide for functional studies of the mtDNA D-loop, which has been incompletely characterized to date.
The nuclear genetic background influences the heteroplasmy landscape
Most of the~1500 known mitochondrial proteins are synthesized from the nuclear genome, including the majority of polypeptide subunits of the oxidative phosphorylation system and the machinery required to replicate and transcribe the mitochondrial genome in situ (1). Selection for or against specific mtDNA variants must therefore occur in the context of a specific nuclear genetic background. To explore this, we identified 12,933 individuals for whom a confident mtDNA haplogroup could be predicted ( fig. S10) . We compared the haplogroup of each individual with the corresponding nuclear genetic ancestry and identified three distinct groups of individuals: (i) a haplogroup-matched group (n = 11,867, 91.7%), in which the mtDNA haplogroup was concordant with the nuclear ancestry; (ii) a haplogroupmismatched group (n = 295, 2.3%), in which the nuclear ancestry and mtDNA were from different human populations; and (iii) a group for which the nuclear ancestry could not be reliably determined (n = 771, 6.0%) (Fig. 6, A and B, and fig. S10 ). Subsequent analyses focused on the haplogroupmatched and -mismatched groups (9) .
In the matched group, 8159 heteroplasmic variants at 3854 of the 16,569 distinct sites on the mitochondrial genome were present, and in the mismatched group, 195 heteroplasmic variants at 163 distinct sites were present. The mean number of heteroplasmic variants and mean HF were not statistically different between the matched and mismatched groups ( fig. S11) . Next, we studied distinct heteroplasmic sites in 10,179 of the 12,933 individuals who were not related on the basis of their nuclear genome (9414 in the matched group, 217 in the mismatched group, and 548 in the third group). Distinct heteroplasmic sites were more likely to affect known haplogroup specific sites (26) than the rest of the mitochondrial genome (P < 2.2 × 10 −16 , Fisher's exact test), particularly within the mismatched group (P = 0.001, odds ratio = 1.70, 95% CI = 1.22 to 2.36, Fisher's exact test) (Fig. 6C) .
We extracted 2641 haplogroup-specific variants present in only one superpopulation (European, Asian, or African) on the world mtDNA phylogeny (26) . We built a predictive model of transmission of these variants using logistic regression in 9385 unrelated European and Asian nuclear ancestries using 2215 European-specific (n = 940) and Asian-specific (n = 1275) variants on the mtDNA phylogeny, omitting the Africans because of the diversity and small number (figs. S10 and S12) (9) . We included the superpopulation and the logit population allele frequency as covariates. We also included a dummy variable indicating whether the variant matched the mitochondrial ancestry of the individual carrying the variant. Finally, for the matched and mismatched groups, we included a separate variable indicating whether the variant superpopulation matched the nuclear ancestry of the individual who carried the variant.
We fitted the model to 768 heteroplasmic variants in 9179 unrelated matched individuals and 30 heteroplasmic variants in 206 unrelated mismatched individuals (9). The heteroplasmic variants in the mismatched group were significantly more likely to match the ancestry of the nuclear genetic background than the mtDNA background on which the heteroplasmy occurred (P = 2.9 × 10 −4
, coefficient estimate = 0.85, SD = 0.24, logistic regression) (Fig. 6D and table S4 ). These findings suggest that the previously unidentified mtDNA variants underwent selection to match the nuclear genome. Given the high mutation rate of the mitochondrial genome and the patterns we observed over one generation, the selective process is likely to occur within the female germ line.
To independently validate this finding, we repeated our analysis with an additional 40,325 whole-genome sequences recruited through the Genomics England 100,000 Genomes Rare Disease Main Programme (9) . There were 36,038 individuals in a haplogroup-matched group, 1098 in a haplogroup-mismatched group, and 3124 in a group for which the nuclear ancestry could not be reliably determined (figs. S12 and S13). As before, we focused on the European-and Asianspecific variants observed in 23,931 unrelated European and Asian individuals. We fitted the same logistic regression model to 1942 heteroplasmic variants in 23,277 unrelated matched individuals and 67 heteroplasmic variants in 654 unrelated individuals for whom the nuclear and mtDNA had a different ancestral origin. Again, the heteroplasmic variants in the mismatched group were more likely to match the ancestry of the nuclear genetic background than the ancestral background of the mtDNA on which the heteroplasmy occurred (P = 1.33 × 10 −3
, coefficient estimate = 0.47, SE = 0.15, logistic regression) (Fig. 6D and table S4 ). An inverse-weighted meta-analysis of the discovery and validation cohorts yielded a significant association across the two datasets (P = 3.3 × 10 −6 , coefficient estimate = 0.59, SE = 0.13). To gain a better understanding of the underlying mechanisms, we studied the gene location and HF of 97 heteroplasmic variants identified in the mismatched groups across both the discovery and validation studies. Potentially functional variants were found in the noncoding region and RNA genes and also included 14 NS protein-coding variants in the MT-ATP, MT-COX, MT-CYB, and MT-ND regions ( fig. S14 ). This raises the possibility that differences in oxidative phosphorylation and adenosine triphosphate (ATP) synthesis are responsible for the association we observed.
Discussion
Several explanations have been proposed for the high substitution rate of the noncoding mtDNA D-loop, including a high intrinsic mutation rate and/or a permissive sequence relative to the coding regions (30) . The segregation of mtDNA heteroplasmy likely plays a role in shaping D-loop population polymorphisms by a mechanism operating within the female germ line. Similar findings have been seen in Drosophila, where D-loop variants "selfishly" drive segregation favoring a specific mtDNA genotype (31) . These observations have implications for the development of mitochondrial transfer techniques for preventing the inheritance of severe pathogenic mtDNA mutations in humans (32, 33) . After mitochondrial transfer,~15% of human embryonic stem cell lines show reversion to the original mtDNA genotype (33) (34) (35) . The reasons for this are not fully understood, but the selective propagation of D-loop heteroplasmy is a plausible explanation. Our findings implicate the nuclear genome in this process. This places greater emphasis on matching both nuclear and mtDNA backgrounds when selecting potential mitochondrial donors in order to minimize the possibility of nuclearmitochondrial incompatibility after mitochondrial transfer.
In cases of heteroplasmic mtDNA, one allele can be preferentially copied or can segregate to high levels in a population of daughter cells. This can lead to changes in mtDNA allele frequency during the lifetime of an individual cell, tissue, or organism through genetic drift (36, 37) . A high level of mtDNA content buffers fluctuations in allele frequency. However, if the number of copies falls below a certain threshold, a "genetic bottleneck" occurs, increasing the possibility of large changes in allele frequency.
There is a~1000-fold reduction in cellular mtDNA content during human germ cell development (38); this phase is followed by a period of intense proliferation and migration when germ cells migrate to form the developing gonad (39) . This process depends on oxidative phosphorylation and is accompanied by a massive increase in mtDNA levels (38) . Under these conditions, selection against variants that compromise mitochondrial ATP synthesis will occur. On the other hand, variants that promote mtDNA replication will have an advantage, potentially explaining the preferential transmission of specific D-loop variants. Subtle selective pressures will have maximal impact at this time, so the nuclear genetic influence we observed will most likely come into play during this critical period of development. Rather than being a direct analysis of the germ line, our study was based on wholeblood DNA, so it is possible that tissue-specific differences in heteroplasmy come into play. However, our analysis indicates that, at the 9 of 12 population level, human mtDNA is influenced by selective forces acting within the female germ line and modulated by the nuclear genetic background. These forces are apparent within one generation and ensure consistency between the two independent genetic systems, shaping the current world mtDNA phylogeny.
Materials and methods

Participants, approvals, and sequence acquisition
The primary data were obtained by whole-genome sequencing (WGS) from whole-blood DNA from 13,037 individuals in the NIHR BioResourceRare Diseases and 100,000 Genomes Project Pilot studies (table S5) (21) After quality control (QC) [see below and (9)], 12,975 samples (including 1526 mother-offspring pairs) were included in this study. For demographics, see (9) . Ethical approval was provided by the East of England Cambridge South national research ethics committee under reference number 13/EE/0325. WGS was performed using the Illumina TruSeq DNA PCR-Free sample preparation kit (Illumina, Inc.) and an Illumina HiSeq 2500 sequencer, generating a mean depth of 45× (range from 34× to 72×) and greater than 15× for at least 95% of the reference human genome ( fig. S8A ).
Extracting mitochondrial sequences, quality control, and variant detection WGS reads were aligned to the Genome Reference Consortium human genome build 37 (GRCh37) using Isaac Genome Alignment Software (version 01.14; Illumina, Inc.). Reads aligning to the mitochondrial genome were extracted from each BAM file and analyzed using MToolBox (v1.0) (8, 9) . Variant Call Files (VCFs) and the merged VCF were normalized with bcftools and vt (40) (41) (42) , and duplicated variants were dropped with vt. The final VCF was annotated using the Variant Effect Predictor (VEP) (43) . Further QC was carried out as described (9) . Potential DNA cross-contamination was investigated using verifyBamID (44) in the nuclear genome and mtDNA variant calls (9) .
Determining matched and mismatched groups
The pairwise relatedness and nuclear ancestry were estimated using nuclear genetic markers as described (9) . MtDNA haplogroup assignment was performed using HaploGrep2 (26, 45) . We then compared the mtDNA phylogenetic haplogroup with the nuclear genetic ancestry in the same individual and identified three distinct groups of individuals as described in the text.
Defining previously unknown variants
Variants were considered to be previously unknown if they were absent from 1000 Genomes datasets and dbSNP and were seen in no more than one individual among 30,506 NCBI mtDNA sequences (5).
MtDNA mutational spectra and signature
Mutational spectra were derived from the reference and alternative alleles as described (24, 46) .
Probability of maternal mtDNA transmission
We modeled the probability of transmission of heteroplasmic variants observed in the mothers using the following logistic regression model
where y ijl ¼ 1 if the lth variant within mitochondrial genomic region j in mother i was transmitted and is zero otherwise; j ¼ 0; 1; 2; 3; or 4 denote the coding, D-loop, rRNA, tRNA, and remainder sequences, respectively; w ijl is the logit of the HF of the lth variant within mitochondrial genomic region j in mother i; and z ijl ¼ 1 if the lth variant within mitochondrial genomic region j in mother i was observed in no individuals from the 1000 Genomes datasets, dbSNP, and at most one individual among 30,506 NCBI mtDNAs; otherwise, it was equal to zero.
Homoplasmic allele frequency in the population and heteroplasmic variants
We fitted a logistic regression model to explore the relationship between the homoplasmic allele frequency in the general population and the rate at which individuals who are not homoplasmic for the alternate allele are heteroplasmic (9) .
Selecting haplogroup-specific variants on the mtDNA phylogenetic tree
We extracted 4476 single-nucleotide variants (SNVs) present on the mtDNA phylogenetic tree (26) , then focused on SNVs either present in only one superpopulation (European, Asian, or African) or present in two superpopulations but commonly seen in one population (>1%) and not seen (or seen extremely rarely) in the other population in 17,520 mtDNAs (5). This selected 2641 haplogroup-specific variants, including 426 African variants, 1275 Asian variants, and 940 European variants.
Nuclear genome ancestry and mtDNA heteroplasmic variants
We modeled the presence or absence of a heteroplasmic variant in a particular individual using logistic regression. We considered only the 2215 mtDNA variants from more than 4000 haplogroupspecific variants that are present exclusively in European or Asian branches of the world mtDNA phylogeny (26) , as this allows unambiguous assignation of mitochondrial ancestry to each variant. To avoid the potential for bias induced by recent shared ancestry between individuals, we considered only the 9385 unrelated Asian or European individuals in matched and mismatched groups. We fitted the following logistic regression model logit Pðy ij ¼ 1Þ ¼ a þ bx j þ gv j þ h1 zi ¼xj þ w1 xj ¼wi ∩zi¼wi þ y1 xj ¼wi ∩zi ≠wi where y ij ¼ 1 if variant j is heteroplasmic in individual i and is zero otherwise; x j ¼ 1 if the ancestry of variant j is European and is zero otherwise; v j is the logit of the homoplasmic allele frequency of variant j in 30,506 NCBI samples; z i ¼ 0; 1; or 2 depending on whether the mitochondrial ancestry of individual i is Asian, European, or African, respectively; and w i ¼ 1 if the nuclear ancestry of individual i is European and is zero otherwise. The indicator variable 1 evaluates to 1 if the conditions in its subscript are met and to zero otherwise.
Validation dataset
We repeated the nuclear-mtDNA ancestry analysis in 42,799 WGS from whole-blood DNA in the Genomics England 100,000 Genomes Rare Disease Main Programme aligned to GRCh37 or/and hg38 using the same bioinformatics pipeline. See (9) for details.
